Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000107

Director acquired 62,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. Director 2022-07-19 Option exercise +62,500 $0.68 $42,500 151,721 D
Derivatives
Krognes Steve E. Director 2022-07-19 Option exercise · Stock Option (right to buy) −62,500 0 D
Loading xslF345X03/wf-form4_165844658516817.xml…